VAERS reports by lot

Pfizer COVID-19 lot 6H9694: VAERS reports

24 VAERS reports list lot 6H9694 as a Pfizer COVID-19 vaccine, received between 2022-09-10 and 2023-08-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2830%
Gastrointestinal1920%
Neurological1213%
Respiratory1011%
Musculoskeletal66%
Cardiac / Cardiovascular55%
Allergic / Anaphylactic44%
Dermatological (non-injection-site)44%
Psychiatric / Neuropsychiatric44%
Thrombotic / Hematological11%
Injection-site / Local reaction11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida3
New Jersey2
Pennsylvania2
Utah2
New York2
Massachusetts1
Virginia1
North Carolina1
Kansas1
South Carolina1
Iowa1
California1

Reports by month received

2022-094
2022-106
2022-114
2022-121
2023-021
2023-033
2023-043
2023-071
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.